Tharimmune (THAR) Stock Chart & Stock Price History $1.59 +0.11 (+7.36%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tharimmune Stock Price Performance The Tharimmune (THAR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 69.04%, with a year-to-date return of -22.91%. In the past month, the stock has increased 2.28%, reflecting recent market activity. As of the latest close, Tharimmune traded at $1.48 with a market cap of $3.94 million and volume of 7,181 shares. Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.74%1 Month Performance+2.28%3 Month Performance+7.93%Year-To-Date Performance-22.91%1 Year Performance-69.04% THAR Stock Chart for Tuesday, June, 3, 2025 THAR Chart by TradingView Tharimmune Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/02/2025$1.49$1.48-0.67%$1.49$1.427,181 shs$3.94 million05/30/2025$1.48$1.49+0.68%$1.50$1.4022,725 shs$3.97 million05/29/2025$1.41$1.48+4.62%$1.49$1.386,822 shs$3.94 million05/28/2025$1.43$1.41-0.73%$1.44$1.3912,693 shs$3.76 million05/27/2025$1.36$1.43+4.96%$1.45$1.325,735 shs$3.79 million05/26/2025$1.36$1.36$1.39$1.2942,139 shs$3.61 million05/23/2025$1.37$1.36-0.91%$1.39$1.2942,139 shs$3.61 million05/22/2025$1.35$1.37+1.48%$1.39$1.353,848 shs$3.65 million05/21/2025$1.48$1.35-8.78%$1.48$1.358,443 shs$3.59 million05/20/2025$1.43$1.48+3.24%$1.51$1.4026,602 shs$3.94 million Get the Latest News and Ratings for THAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. 05/19/2025$1.33$1.43+7.79%$1.50$1.2865,061 shs$3.82 million05/16/2025$1.33$1.33+0.38%$1.36$1.2625,516 shs$2.94 million05/15/2025$1.40$1.33-5.36%$1.38$1.2640,050 shs$2.93 million05/14/2025$1.44$1.40-2.78%$1.45$1.3236,422 shs$3.09 million05/13/2025$1.56$1.44-7.69%$1.57$1.4328,655 shs$3.18 million05/12/2025$1.51$1.56+3.31%$1.58$1.4541,493 shs$3.45 million05/09/2025$1.50$1.51+0.67%$1.53$1.486,297 shs$3.34 million05/08/2025$1.54$1.50-2.60%$1.58$1.4167,829 shs$3.32 million05/07/2025$1.65$1.54-6.67%$1.66$1.4859,347 shs$3.40 million05/06/2025$1.56$1.65+5.77%$1.68$1.49382,957 shs$3.65 million05/05/2025$1.53$1.56+1.95%$1.68$1.5296,814 shs$3.45 million05/02/2025$1.55$1.53-1.28%$1.58$1.41143,617 shs$3.23 million Related Companies Cocrystal Pharma Stock Chart Allarity Therapeutics Stock Chart MEI Pharma Stock Chart Equillium Stock Chart Edesa Biotech Stock Chart AlloVir Stock Chart NextCure Stock Chart Moleculin Biotech Stock Chart 23andMe Stock Chart iBio Stock Chart Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:THAR) was last updated on 6/3/2025 by MarketBeat.com Staff From Our PartnersDo You Believe In President Trump? Answer This 1 QuestionThey said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThe Social Security Changes No One’s Talking AboutWhile most Americans worry about their next Social Security check... something far bigger is happening behind ...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy THAR Stock Free THAR Stock Alerts